Novozymes acquires GroPep Ltd.
Novozymes A/S announced the successful conclusion of the proposal to acquire 100% of the issued shares of GroPep Limited ("GroPep") at AUD 2.05 per share. The acquisition, which will be effected by way of a Scheme of Arrangement, was subject to certain limited conditions which have now all been fulfilled satisfactorily.
The total aggregate consideration to holders of GroPep shares and options is approximately AUD 100 million (DKK 446 million). The transaction value corresponds to approximately DKK 394 million on a cash and interest-bearing debt-free basis. Payment is expected to be made on December 12, 2006, which will be the official implementation date.
Novozymes expects GroPep to be de-listed from the Australian Stock Exchange (ASX) November 28, 2006. The new name of the company will be Novozymes GroPep Ltd. The company will become a wholly owned indirect subsidiary of Novozymes and will be included in Novozymes' consolidated accounts as of the closing date.
Other news from the department business & finance

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.